Clinical trial SN201
A multicentric phase 1/2 trial to evaluate the safety and efficacy of SOT102 as monotherapy and in combination with standard of care treatment in patients with gastric and pancreatic adenocarcinoma (Sotio - SN201)
| Cancers | |
|---|---|
| Organ | Multiple |
| Trial status | Trial open for recruitment |
| Investigator | |
| Trial type |
Interventional with experimental drug
|
| Phase | Trial phase 1/2 |
| Academic trial | Non |
| Sponsor | Sotio |
| EudraCT Identifier | 2021-005873-25 |
| ClinicalTrials.gov | https://clinicaltrials.gov/ct2/show/NCT05525286 |
| Last update |